Blurring the Lines
Pharma, Generics Firms See More Green on the Other Side
By Trista Morrison
Monday, February 22, 2010
Cephalon Inc.'s recent $590 million purchase of Swiss generics player Mepha AG was intended to create a balanced portfolio of branded products and generics.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.